Dale A. Sander, CFO and Chief Corporate Development Officer at Humacyte, Inc. (HUMA), sold 45,887 shares at $0.90 ($41K) on 2026-05-18, disclosed to the SEC on 2026-05-20.
Scheduled sale ($41k) by CFO and Chief Corporate Development Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HUMA | BUY | 2022-12-19 | $52K | — | Filing → |
| HUMA | BUY | 2022-05-18 | $9K | — | Filing → |